Long non‐coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis
- 24 December 2020
- journal article
- review article
- Published by Wiley in IUBMB Life
- Vol. 73 (2), 307-327
- https://doi.org/10.1002/iub.2430
Abstract
Long non‐coding RNAs (lncRNA) have been emerged as a novel class of molecular regulators in cancer. They are dysregulated in many types of cancer; however, there is not enough knowledge available on their expression and functional profiles. Lung cancer is the leading cause of the cancer deaths worldwide. Generally, lncRNAs may be associated with lung tumor pathogenesis and they may act as biomarkers for the cancer prognosis and diagnosis. Compared to other invasive prognostic and diagnostic methods, detection of lncRNAs might be a user‐friendly and noninvasive method. In this review article, we selected 27 tumor‐associated lncRNAs by literature reviewing to further discussing in detail for using as diagnostic and prognostic biomarkers in lung cancer. Also, in an in silico target analysis, the “Experimentally supported functional regulation” approach of the LncTarD web tool was used to identifying the target genes and regulatory mechanisms of the selected lncRNAs. The reports on diagnostic and prognostic potential of all selected lncRNAs were discussed. However, the target genes and regulatory mechanisms of the 22 lncRNAs were identified by in silico analysis and we found the pathways that are controlled by each target group of lncRNAs. They use epigenetic mechanisms, ceRNA mechanisms, protein interaction and sponge mechanism. Also, 10, 23, 5, and 28 target genes for each of these mechanisms were identified, respectively. Finally, each group of target genes controls 50, 12, 7, and 2 molecular pathways, respectively. In conclusion, LncRNAs could be used as biomarkers in lung cancer due to their roles in control of several signaling pathways related to lung tumors. Also, it seems that lncRNAs, which use epigenetic mechanisms for modulating a large number of pathways, could be considered as important subjects for lung cancer‐related diagnostic and prognostic biomarkers.Keywords
Funding Information
- University of Tabriz
This publication has 139 references indexed in Scilit:
- Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancerBMC Research Notes, 2013
- The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 ExpressionPLOS ONE, 2013
- The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancerBMC Cancer, 2013
- Identification and Characterization of the First Escherichia coli Strain Carrying NDM-1 Gene in ChinaPLOS ONE, 2013
- Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and AdenocarcinomasGenes & Cancer, 2011
- Expression and Function of a Large Non‐coding RNA Gene XIST in Human CancerWorld Journal of Surgery, 2011
- Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cellsNature Genetics, 2010
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- Noncoding RNAsBiochemistry (Moscow), 2007
- Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAsCell, 2007